The Louisiana Pharmacy Benefit Manager Monitoring Advisory Council met last month with an unusual guest — one who came with a clear conflict of interest.

Dr. Alex Oshmyansky, founder and CEO of the Mark Cuban-backed Cost Plus Drug Company, was invited to brief the council on PBMs . But his company directly competes with them. No PBM representatives were invited to speak or respond. What could have been an informed policy discussion turned into an unbalanced promotional session for a single competitor — and that does not serve patients.

The one-sided hearing

Pharmacy benefit managers have long been in Mark Cuban’s crosshairs . He claims PBMs create “an inefficient market” and lack transparency. Those complaints underpin his partnership with Oshmyansky to form Cost Plus Drug Company,

See Full Page